Join to view full profile
5841 S. MARYLAND AVE.M/C 2115Chicago, IL 60637
Phone+1 773-702-4400
Fax+1 773-702-0963
Dr. Bestvina is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
IL State Medical License 2015 - 2029
IN State Medical License 2025 - 2027
WI State Medical License 2022 - 2023
NC State Medical License 2012 - 2015
Clinical Trials
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Start of enrollment: 2019 Jun 27
- M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2019 Apr 16
- A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) Start of enrollment: 2019 Sep 19
Publications & Presentations
PubMed
- Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.Narjust Florez, Sandip Pravin Patel, Ravi Salgia, Jacob Sands, Erin L Schenk
Cancer. 2026-10-01 - Prolonged survival after systemic immune reactivation by aglatimagene besadenovec plus valacyclovir in immune checkpoint inhibitor-refractory non-small cell lung cancer.Charu Aggarwal, Daniel Sterman, Jessica Dwyer, Erin R Alesi, Fabien Maldonado
Journal for Immunotherapy of Cancer. 2026-09-28 - Pan-tumor spatial transcriptomics reveals conserved properties of tumor organization.Vivek Behera, Alexander Guzzetta, Hannah Giba, Ue-Yu Pen, Anna Di Lello
Cell Reports. Medicine. 2026-09-15
Press Mentions
ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
Combining Immune Checkpoint and VEGF Inhibitors Improves Survival in Pretreated NSCLCJune 4th, 2022
Oncogene-Specific Advocacy Groups Bring a Patient-Centric Perspective to Studies of Lung CancerNovember 18th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
